NCT07774962

Brief Summary

In septic shock, restoring large-vessel (macrocirculatory) perfusion-reflected by a normal capillary refill time (CRT)-does not always mean that oxygen use at the tissue level has recovered. This mismatch, sometimes called loss of hemodynamic coherence, may be detectable by comparing CRT with the oxygen extraction ratio (O₂ER), a marker of how much oxygen the tissues are extracting from the blood. Patients whose CRT has normalized but whose O₂ER remains abnormal-either too high (suggesting oxygen delivery that is insufficient for demand) or too low (suggesting microcirculatory shunting)-are considered to have a "discordant" perfusion phenotype. This prospective, single-center, observational cohort study aims to determine how often this CRT-O₂ER discordance occurs at the 6th hour of resuscitation in adult patients with septic shock, and whether it is associated with 28-day mortality. Approximately 100 consecutive adult patients diagnosed with septic shock (with pre-existing central venous and arterial catheters) will be followed. Clinical and laboratory measurements-including CRT, O₂ER, lactate, mottling score, and organ dysfunction scores-will be recorded at hours 0, 6, 12, and 24, with the main phenotype grouping performed at hour 6. The study is purely observational: CRT is a painless, non-invasive bedside measurement, and O₂ER is calculated from blood gas samples already drawn as part of routine care, so no additional interventions or blood draws are performed for research purposes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
9mo left

Started Aug 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Aug 2026Jul 2027

First Submitted

Initial submission to the registry

August 15, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

August 17, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 19, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 17, 2027

Last Updated

August 19, 2026

Status Verified

August 1, 2026

Enrollment Period

10 months

First QC Date

August 15, 2026

Last Update Submit

August 15, 2026

Conditions

Keywords

Capillary Refill TimeOxygen Extraction RatioTissue PerfusionScvO2MicrocirculationHemodynamic CoherenceLactateObservational Cohort Study

Outcome Measures

Primary Outcomes (2)

  • Prevalence of the discordant CRT-O₂ER phenotype

    Proportion of patients classified as having a discordant perfusion phenotype (normalized CRT ≤3 s with an abnormal O₂ER, i.e., \>30% or \<20%; combined Group 2a + Group 2b) at hour 6, reported with 95% confidence interval.

    At hour 6 of resuscitation (6 hours after vasopressor initiation)

  • 28-day all-cause mortality

    All-cause mortality at 28 days, and its association with the hour-6 perfusion phenotype.

    28 days from Hour 0 (vasopressor initiation)

Secondary Outcomes (7)

  • ICU length of stay

    Through study completion, up to 28 days

  • Hospital length of stay

    Through study completion, up to 28 days

  • Duration of mechanical ventilation

    Through study completion, up to 28 days

  • Time to vasopressor weaning

    From Hour 0 up to 28 days

  • Vasopressor-free days

    28 days

  • +2 more secondary outcomes

Other Outcomes (2)

  • Diagnostic performance of the O₂ER threshold for mortality

    Hour 6 measurement; mortality at 28 days

  • Inter-rater reliability of CRT measurement

    Hour 6, first 20-30 patients

Study Arms (1)

septic schoc cohort

Consecutive adult patients (≥18 years) admitted to the intensive care unit and diagnosed with septic shock according to the Surviving Sepsis Campaign (SSC) 2026 guideline, who have pre-existing central venous and arterial catheters. Patients are prospectively followed while receiving standard care, with serial measurements at hours 0, 6, 12, and 24 (time zero = vasopressor initiation). At hour 6, patients are classified into perfusion phenotypes based on capillary refill time (CRT) and oxygen extraction ratio (O₂ER): concordant normal, discordant with high O₂ER, discordant with low O₂ER, and concordant abnormal. The primary group of interest is the combined discordant phenotype (normalized CRT with abnormal O₂ER).

Diagnostic Test: Capillary refill time (CRT)Diagnostic Test: Oxygen extraction ratio (O₂ER) assessment

Interventions

Non-invasive, standardized bedside measurement of capillary refill time on the right index finger.

septic schoc cohort

Oxygen extraction ratio calculated as (SaO₂ - ScvO₂)/SaO₂ from routinely obtained arterial and central venous blood gases.

septic schoc cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive adult patients (≥18 years) admitted to a single-center intensive care unit and diagnosed with septic shock according to the Surviving Sepsis Campaign (SSC) 2026 guideline, who already have a central venous catheter and an arterial line in place as part of their clinical care. Patients are enrolled from all admission sources (emergency department, ward, operating room, or external referral) and followed prospectively while receiving standard treatment. Patients with active bleeding, ongoing ECMO, conditions that make capillary refill time measurement unreliable (e.g., Raynaud phenomenon or significant peripheral vascular disease), death within the first 6 hours, or inability to obtain hour-6 CRT or blood gas measurements are not included.

You may qualify if:

  • Age ≥ 18 years
  • Diagnosis of septic shock according to the Surviving Sepsis Campaign (SSC) 2026 guideline
  • Presence of both a central venous catheter and an arterial line

You may not qualify if:

  • Active bleeding
  • Ongoing extracorporeal membrane oxygenation (ECMO)
  • Raynaud phenomenon or significant peripheral vascular disease that makes capillary refill time measurement unreliable (e.g., critical ischemia, amputation, digital ulcer/necrosis, or inability to measure on the right index finger)
  • Death within the first 6 hours
  • Inability to obtain hour-6 CRT or blood gas (phenotyping not possible)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Basaksehir Cam and Sakura City Hospital

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Shock, SepticSepsis

Interventions

Physical Examination

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

Tugba Yesilyurt Dogu, Intensive Medicine Care Fellow

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Intensive Care Medicine Fellow

Study Record Dates

First Submitted

August 15, 2026

First Posted

August 19, 2026

Study Start

August 17, 2026

Primary Completion (Estimated)

June 17, 2027

Study Completion (Estimated)

July 17, 2027

Last Updated

August 19, 2026

Record last verified: 2026-08

Locations